WE
Therapeutic Areas
Merakris Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MTX-001 | Venous Leg Ulcers (Chronic Wound Healing) | Phase 2 |
| Opticyte Matrix | Ophthalmic Surgical Procedures | Commercial |
| Dermacyte Matrix | Advanced Wound Care | Commercial |
Leadership Team at Merakris Therapeutics
TC
T. Christopher Broderick
Director & Chief Executive Officer
DR
Dr. Roger Ilagan
Chief Scientific Officer